Psychological Aspects and Patients Compliance to Restricted-protein Regimens in Chronic Kidney Disease
NCT ID: NCT02345759
Last Updated: 2018-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2013-01-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Relationship Between Salt Restriction and Taste Sensitivity in Patients With Chronic Kidney Disease
NCT03397550
Supplemented Very Low Protein Diet and the Progression of Chronic Kidney Disease
NCT02031224
Efficacy of the 6-point Diet
NCT01865526
Could Ketoanalogue-supplemented Low Protein Diet Defer Dialysis in Advanced Diabetic Kidney Disease? (K-DDD)
NCT03415074
Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease
NCT00755690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Although protein-restricted diets are used for more than a century in patients with advanced Chronic Kidney Disease (CKD), their efficacy and safety is still debatable. Enough evidence has being accumulated on their role in postponing dialysis initiation in compliant patients. Consequently, the long-term compliance to the diet is discussed. Psychological aspects of compliant patients are certainly involved. Identification of certain psychological predictors of dietary compliance could help to select the patients who are more likely to be compliant and therefore to benefit from such an intervention. Moreover, short-term or long-term psychological intervention addressing these factors could increase patient long-term compliance.
Accordingly, we are aiming to evaluate psychological characteristics of Chronic Kidney Disease patients in relation with their compliance to protein-restricted regimens.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Keto-diet group
Vegetarian very low protein regimen (0.3 g proteins/kg ideal body weight per day) supplemented with ketoanalogues of essential amino acids (Ketosteril®, Fresenius Kabi, Bad Homburg, Germany), 1 capsule for every 5 kg of ideal dry body weight per day.
No interventions assigned to this group
Conventional LPD group
0.6 g/kg per day, including high biological value proteins
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* stage 4+ CKD
* good nutritional status (Subjective Global Assessment score A/B and serum albumin ≥3.5 g/dL)
* declared potentially good compliance with a low protein diet and agreed to follow the monitoring schedule are considered for the program
Exclusion Criteria
* uncontrolled diabetes mellitus
* other relevant comorbidities (heart failure, active hepatic disease, digestive diseases with malabsorption, inflammation/anti-inflammatory therapy)
* uremic complications (pericarditis, polyneuropathy)
* feeding inability (anorexia, nausea)
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anemia Working Group Romania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gabriel Mircescu, Professor of Nephrology
Role: STUDY_CHAIR
Spitalul Clinic de Nefrologie "Dr Carol Davila"
Liliana Garneata, MD, PhD
Role: STUDY_DIRECTOR
Spitalul Clinic de Nefrologie "Dr Carol Davila"
Cristina Drugau, MD
Role: PRINCIPAL_INVESTIGATOR
Spitalul Clinic de Nefrologie "Dr Carol Davila"
Evy Dehelean, Psychologist
Role: PRINCIPAL_INVESTIGATOR
International Health Care Systems Romania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spitalul Clinic de Nefrologie "Dr Carol Davila"
Bucharest, , Romania
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AWG 5/2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.